CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Cash flows from operating activities:
Net income	$ 339,781	$ 295,665	$ 405,031
Adjustments to reconcile to net cash provided by operating activities:
Depreciation and amortization	173,792	117,967	102,469
Deferred income taxes	19,402	58,889	14,350
Gains on sale of assets	(1,177)	(184)	(10,836)
Stock-based compensation	29,401	26,567	24,587
Loss on extinguishment of debt	38,810	0	0
Gain on deal contingent derivatives	(12,505)	0	0
Pension contributions	(22,433)	(39,298)	(46,347)
Litigation settlement	0	(56,000)	0
Product recall claim settlement, net of insurance proceeds received	235	0	0
Foreign currency gain on liquidation of entity	0	(12,217)	0
Changes in assets and liabilities, net of acquisitions:
Changes in assets and liabilities, net of acquisitions:	(49,958)	(68,851)	(21,544)
Trade receivables	(117,641)	(18,911)	15,452
Inventories	55,136	29,114	(7,642)
Accounts payable	(2,289)	19,144	12,133
Accruals for incentive compensation	(5,279)	22,679	49,103
Other assets	(19,219)	(3,866)	(1,067)
Other liabilities	11,519	20,058	14,450
Net cash provided by operating activities	437,575	390,756	550,139
Cash flows from investing activities:
Cash paid for acquisitions, net of cash received	(4,857,343)	(192,328)	(236,836)
Additions to property, plant and equipment	(170,094)	(128,973)	(126,412)
Additions to intangible assets	(3,326)	0	0
Proceeds from disposal of assets	8,176	16,139	6,856
Proceeds from disposal of subsidiaries, net of cash held	10,157	0	0
Maturity of net investment hedges	(2,642)	1,434	637
Proceeds from life insurance contracts	1,837	3,798	292
Net cash used in investing activities	(5,013,235)	(299,930)	(355,463)
Cash flows from financing activities:
Cash dividends paid to shareholders	(230,218)	(206,118)	(184,897)
Decrease in revolving credit facility and short term borrowing	(927)	(4,499)	(131,074)
Deferred financing costs	(33,668)	(5,373)	(5,788)
Repayments of debt	(376,625)	(250,000)	(125,000)
Proceeds from issuance of long-term debt	(3,256,742)	(498,250)	(555,559)
Proceeds from sales of equity securities, net of issuance costs	2,268,094	0	0
Gain (loss) on pre-issuance hedges	12,505	(5,310)	(3,244)
Proceeds from issuance of stock in connection with stock plans	0	329	813
Employee withholding taxes paid	(9,725)	(11,768)	(13,353)
Purchase of treasury stock	(15,475)	(58,069)	(127,443)
Net cash provided by (used in) financing activities	4,870,703	(42,558)	(34,427)
Effect of exchange rate changes on cash and cash equivalents	(14,567)	(4,214)	(18,245)
Net change in cash, cash equivalents and restricted cash	280,476	44,054	142,004
Cash, cash equivalents and restricted cash at beginning of year	368,046	323,992	181,988
Cash, cash equivalents and restricted cash at end of year	648,522	368,046	323,992
Cash paid for:
Interest, net of amounts capitalized	117,581	55,440	50,576
Income taxes	116,138	107,390	107,898
Noncash investing activities:
Accrued capital expenditures	$ 33,844	$ 37,556	$ 26,049